Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

BetterLife Pharma Receives $127,500 From Warrant Exercises (OTC: BETRF)

BetterLife Pharma Inc. (OTC: BETRF) appointed Charles Duncan, PhD, as a director and chair of its audit committee in August 2026. The appointment came with 500,000 stock options exercisable at $0.285 per share, alongside a further option grant carrying the same exercise price.

Vinay Lochav | 11 September 2026

BioCardia (NASDAQ: BCDA) Sets September 14 CardiAMP and Platform Presentation

BioCardia, Inc. (NASDAQ: BCDA) will present its CardiAMP program and related technology platforms at the H.C. Wainwright conference beginning September 14 in New York.

Vinay Lochav | 11 September 2026

Biohaven (NYSE: BHVN) Pauses BHV-7000 Enrollment, Over 1,200 Dosed

Biohaven Ltd. (NYSE: BHVN) is pausing new enrollment in its BHV-7000 program after the FDA imposed a partial clinical hold tied to a metabolite observed during rodent testing. More than 1,200 participants have received BHV-7000 across development, and dosing can continue for patients already …

Vinay Lochav | 11 September 2026

Burning Rock Biotech Revenue Falls 9.3% to RMB134.7M (NASDAQ: BNR)

Burning Rock Biotech’s second-quarterRevenuefell 9.3% to RMB134.7 million (US$19.9 million), while net loss rose to RMB18.4 million (US$2.7 million). For investors, the results show stronger in-hospital revenue alongside weaker central-laboratory and pharma services revenue, while the company points toLong-term Growthand new registration certificates.Key HighlightsBurning …

Vinay Lochav | 11 September 2026

Candel Therapeutics (NASDAQ: CADL) Adds Director With 64,000-Share Option

Candel Therapeutics, Inc. (NASDAQ: CADL) appointed Martine Zimmermann to its board with an option to purchase 64,000 common shares. The appointment adds regulatory and quality expertise as Candel advances toward a plannedBiologicsLicense Application submission and potential commercial readiness.

Vinay Lochav | 11 September 2026

Cellyan Biotechnology (NASDAQ: HKPD) Sets Extraordinary Meeting for September 21, 2026

Cellyan Biotechnology Co. Ltd (NASDAQ: HKPD) is seeking shareholder approval for a share consolidation that it believes could help maintain its Nasdaq listing if the Class A ordinary share closing price exceeds $1.00 per share. The company also cautions that the action may not …

Vinay Lochav | 11 September 2026

Charlestowne Senior Village LLC Offers Investors $6.2M Healthcare Raise

The notice places the activity in the Other Health Care category and identifies Kevin Francis Kast as an executive officer. The offering notice carries the date 28 August 2026.

Vinay Lochav | 11 September 2026

Braskem (NYSE: BAK) Reports 42.150 Treasury Preferred Shares Balance

Braskem S.A. (NYSE: BAK) reports an opening balance of 42.150 treasury shares in its Class A preferred share category. The balance is presented in the company’s monthly securities information under Article 11 of CVM Instruction #44/2021. The record identifies the treasury-share position and its …

Vinay Lochav | 11 September 2026

BRASKEM SA (NYSE: BAK) Board Approves BRL 1.85B Petrobras Gas Amendment

BRASKEM SA (NYSE: BAK) amended its natural gas supply agreement with Petrobras, setting an estimated post-amendment contract value of BRL 1,850,000,000. The arrangement covers preferential supply for Braskem facilities in Brazil or adjustments to its portfolio.

Vinay Lochav | 11 September 2026

BROWN & BROWN Adds 2026 Company Overview (NYSE: BRO)

Brown & Brown, Inc. (NYSE: BRO) has set out its 2026 Company Overview, covering operating measures and cautions tied to future results.

Vinay Lochav | 11 September 2026
Support

Hi! How can we help you today?

Loading…